Sean C. Domnick of Rafferty Domnick Cunningham & Yaffa Says AI’s Biggest Impact on Medicine May Be How Doctors Exercise Clinical Judgment
Sean C. Domnick, a shareholder at Rafferty Domnick Cunningham & Yaffa, was featured in a GlobeNewswire release discussing his commentary published by KevinMD, titled “Can Independent Medical Judgement Survive AI in Medicine?” The article examines how artificial intelligence is changing healthcare and raises important questions about the continued role of independent clinical judgment in medical decision-making.
Drawing on his experience as a medical malpractice attorney, Domnick explores the potential risks of physicians becoming overly reliant on AI-generated recommendations. While these technologies can help identify diseases earlier, detect abnormalities, and reduce medical errors, he emphasizes that they should support rather than replace a physician’s professional judgment.
The commentary highlights how medical decisions often involve uncertainty, requiring physicians to question initial findings, investigate unusual symptoms, and consider alternative diagnoses. As AI becomes more integrated into clinical settings, Domnick encourages healthcare professionals, hospitals, and regulators to consider how these tools can improve patient care without diminishing physicians’ responsibility to independently evaluate each case.
His perspective underscores the importance of balancing technological innovation with human expertise, particularly when medical decisions carry serious consequences for patient safety.
Rafferty Domnick Cunningham & Yaffa continues its work representing individuals and families affected by medical malpractice and preventable harm.
